Gladstone Institutes, J. David

Total Awards: 
Award Value: 
Institution type: 
Not for profit
Short Name: 

Awards to the Institution

Program Investigator Award Title Award Valuesort ascending
Research Leadership Todd McDevitt Engineering microscale tissue constructs from human pluripotent stem cells $5,884,058
Early Translational III Deepak Srivastava Direct Cardiac Reprogramming for Heart Regeneration $5,795,871
Research Training II Robert Mahley Gladstone CIRM Scholars Program $4,869,300
Comprehensive Grant Deepak Srivastava microRNA Regulation of Cardiomyocyte Differentiation from Human Embryonic Stem Cells $2,994,719
New Faculty II Yadong Huang Defining the Isoform-Specific Effects of Apolipoprotein E on the Development of iPS Cells into Functional Neurons in Vitro and in Vivo $2,757,303
New Faculty II Benoit Bruneau Induction of cardiogenesis in pluripotent cells via chromatin remodeling factors $2,723,653
Quest - Discovery Stage Research Projects Deepak Srivastava Use of Human iPSC-derived Endothelial Cells for Calcific Aortic Valve Disease Therapeutics $2,400,048
Quest - Discovery Stage Research Projects Deepak Srivastava Direct Cardiac Reprogramming for Regenerative Medicine $2,400,048
Training Grant I-2 Robert Mahley Gladstone CIRM Scholar Program $2,192,073
Early Translational IV Steven Finkbeiner Development of Novel Autophagy Inducers to Block the Progression of and Treat Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Diseases $2,049,053
Therapeutic Translational Research Projects Yadong Huang Human iPSC-derived GABAergic Progenitors for Alzheimer’s Disease Treatment $1,900,000
New Cell Lines Bruce Conklin Induced Pluripotent Stem Cells for Cardiovascular Diagnostics $1,708,560
Shared Labs Deepak Srivastava The Gladstone CIRM Shared Human Embryonic Stem Cell Core Laboratory $1,698,515
New Cell Lines Robert Farese Establishment of Frontotemporal Dementia Patient-Specific Induced Pluripotent Stem (iPS) Cell Lines with Defined Genetic Mutations $1,696,424
Basic Biology III Deepak Srivastava Mechanisms of Direct Cardiac Reprogramming $1,572,380
Basic Biology IV Sheng Ding A new paradigm of lineage-specific reprogramming $1,568,395
Basic Biology IV Benoit Bruneau Epigenetic regulation of human cardiac differentiation $1,568,148
Quest - Discovery Stage Research Projects Li Gan Develop iPSC-derived microglia to treat progranulin-deficient Frontotemporal Dementia $1,547,157
Shared Labs Sheng Ding TSRI Center for hESC Research $1,440,164
Basic Biology IV Steven Finkbeiner Common molecular mechanisms in neurodegenerative diseases using patient based iPSC neurons $1,395,184
New Faculty I Sheng Ding Reprogramming of human somatic cells back to pluripotent embryonic stem cells $1,320,101
Basic Biology V Sheng Ding A novel druggable mechanism to safeguard stem cell genome $1,294,495
Early Translational I Warner Greene Maximizing the Safety of Induced Pluripotent Stem Cells as an Infusion Therapy: Limiting the Mutagenic Threat of Retroelement Retrotransposition during iPSC Generation, Expansion and Differentiation $1,280,001
Shared Labs Deepak Srivastava The Gladstone CIRM Shared Human Embryonic Stem Cell Core Laboratory $842,672
New Cell Lines Sheng Ding Derivation of New ICM-stage hESCs $778,859
SEED Grant Fen-Biao Gao MicroRNAs in Human Stem Cell Differentiation and Mental Disorders $748,800
SEED Grant Warner Greene The APOBEC3 Gene Family as Guardians of Genome Stability in Human Embryonic Stem Cells $717,363
SEED Grant Eric Verdin Role of HDAC in human stem cells pluripotentiality and differentiation $590,997
Conference Deepak Srivastava Keystone Symposia, "Stem Cells and Reprogramming" $50,000
Conference Deepak Srivastava ISSCR - Roddenberry International Symposium on Cellular reprogramming $43,000
Creativity Awards Shannon Noonan Gladstone Summer Scholars (GSS) internship program $35,044
Disease Team Planning Deepak Srivastava Pluripotent Stem Cell–Based Therapy for Heart Disease $13,505
Icon for xls export